Êtes-vous un étudiant de l'EPFL à la recherche d'un projet de semestre?
Travaillez avec nous sur des projets en science des données et en visualisation, et déployez votre projet sous forme d'application sur Graph Search.
Extremely sensitive protein detection is crucial for early diagnosis and monitoring of diseases. Present day’s limit of detection for an antibody-antigen recognition-based immunoassay in serum without having to use special target antigen amplification techniques, like immuno-linked polymerase chain reaction (PCR), is 10 fg/mL, a sensitivity achieved thanks to the use of relatively large sample volumes (40-100 μL). In this thesis, a new method is developed to analyze rare protein biomarkers in a serum sample using a magnetic bead surface coverage assay. The assay protocols are realized on a microfluidic chip having channels, valves, an integrated mixer, and a protein micro-array. The microfluidic chip provides automated analysis, minute sample consumption (5 μL), resulting in an unprecedented 2 fg/mL detection performance for Tumor Necrosis Factor-α (TNF-α) in serum. A first part of the thesis consists in fabricating protein micro-arrays using the surface of immobilized ‘small’ (1.0 μm size) superparamagnetic beads that are placed in microfluidic flow channels. The small beads are immobilized on a glass chip with pre-patterned aminopropyl- trietoxysilane (APTES) structures using an electrostatic self-assembly method. Different target antigens are captured from a flow passing over the micro-array inside the microfluidic channel, and are specifically bound on the small bead surfaces. The presence of target antigens is detected as a fluorescent signal by realizing a sandwich immunocomplex on the capture antibody-functionalized surfaces of the small beads. However, the fluorescent detection method is abandoned due to high fluorescence background levels, resulting in only a 0.25 ng/mL detection limit for mouse immunoglobulin in phosphate-buffered saline. In a second part of the thesis, a polydimethylsiloxane (PDMS) chip having microfluidic channels, valves and an integrated mixer is designed. A new active mixing strategy is performed in the chip using multiple source-sink microfluidic flows. To do so, four different pressure- controlled actuation chambers are arranged on top of the 5 μL volume of the mixing chamber. After microfluidic valves, realized using ‘microplumbing technology’, seal the mixing volume, a virtual source-sink pair is created by pressurizing one of the membranes and, at the same time, releasing the pressure of a neighboring one. This creates microfluidic flows from the squeezed region (source) to the released region (sink) where the PDMS membrane is turned into the initial state. Perfect mixing is 7000-fold faster than achievable with pure diffusion-based mixing. This excellent performance is possible thanks to the implementation of chaotic advection by inducing vortices inside the mixing chamber. A DNA isolation and purification protocol using magnetic beads in the mixing chamber is also performed on-chip, showing the enhanced DNA binding performance due to active mixing. Finally, a new protein detection method is realized in a microfluidic chip. ‘Large’ (2.8 μm size) functionalized superparamagnetic beads specifically capture target antigens from a serum matrix under active microfluidic mixing. Subsequently, the large beads loaded with the antigens gently expose antibody-functionalized small bead patterns on the glass detection chip. During the exposure, attractive magnetic bead dipole-dipole interactions improve the contact between the two bead types and help the antigen-antibody immunocomplex formation, while non- specific large bead adsorption is limited by exploiting viscous drag forces in the microfluidic channel on the detection chip. This efficient transport mimics a biological process, where leukocytes roll and slow down on blood vessel walls by selectin-mediated adhesion for rapid recognition of tissue molecules. Afterwards, the antigen concentration is detected by simply counting the surface pattern-bound large magnetic beads. The new technique allows detection of only a few hundreds of TNF-α molecules (600 yoctomole) spiked in the 5 μL serum sample. This performance, in terms of detectable number of molecules, is at least 20 times better than today’s most-sensitive PCR-free antibody-based methods. Furthermore, the method has the supplementary advantage of being rapid, resulting from the automated assay protocols and the extremely fast (1 minute) antigen capture.
, ,
Martinus Gijs, Diego Gabriel Dupouy, Muaz Salama Abdelmonem Draz